The U.S Food and Drug Administration is authorizing Regeneron's antibody cocktail for some patients who test positive for COVID-19. The FDA said Saturday that it's okay to give it to high-risk ...

Regeneron’s COVID-19 antibody cocktail, casirivimab and imdevimab, reduced the risk of death among hospitalized patients in a phase 3 trial, the drugmaker said June 16. The trial found that adding ...

New data on the COVID-19 antibody therapy Ronapreve (casirivimab + imdevimab), already used to treat non-hospitalized patients in multiple countries, could potentially support expanding its use to ...

Trump received an experimental Regeneron antibody cocktail, remdesivir, dexamethasone, zinc, vitamin D and more during just four days in hospital. He later called the antibody treatment “a cure.” The ...